Lv D - Search Results

1

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.

Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Jie W, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Sun C, Wei H, Li C, Ali SM, Miller VA, Wu Q. Lu S, et al. Among authors: lv d. J Clin Oncol. 2022 Sep 20;40(27):3162-3171. doi: 10.1200/JCO.21.02641. Epub 2022 May 17. J Clin Oncol. 2022. PMID: 35580297 Free PMC article. Clinical Trial.

2

Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer.

Yang HH, Chen XF, Hu W, Lv DQ, Ding WJ, Tang LJ, Jiang JJ, Ye MH. Yang HH, et al. Clin Chem Lab Med. 2009;47(4):452-7. doi: 10.1515/CCLM.2009.094. Clin Chem Lab Med. 2009. PMID: 19222374

3

High PHLPP1 expression levels predicts longer time of acquired resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma.

Xie Y, Lv D, Wang W, Ye M, Chen X, Yang H. Xie Y, et al. Among authors: lv d. Oncotarget. 2017 Aug 1;8(35):59000-59007. doi: 10.18632/oncotarget.19777. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938613 Free PMC article.

4

Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp(a) concentration.

Xu H, Lv D, Meng Y, Wang M, Wang W, Zhou C, Zhou S, Chen X, Yang H. Xu H, et al. Among authors: lv d. Ann Palliat Med. 2020 Mar;9(2):298-307. doi: 10.21037/apm.2020.01.16. Epub 2020 Feb 18. Ann Palliat Med. 2020. PMID: 32075401 Free article.

5

Detection of plasma T790M mutation after the first generation EGFR-TKI resistance of non-small cell lung cancer in the real world.

Li H, Wang J, Zhang G, Li Y, Lin L, Yang H, Zhou J, Zhang L, Lv D. Li H, et al. Among authors: lv d. J Thorac Dis. 2020 Mar;12(3):550-557. doi: 10.21037/jtd.2019.12.122. J Thorac Dis. 2020. PMID: 32274120 Free PMC article.

6

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study.

Zheng J, Cao H, Li Y, Rao C, Zhang T, Luo J, Lv D, Zhu Y, Zhou J, Zhou J. Zheng J, et al. Among authors: lv d. Lung Cancer. 2020 Sep;147:130-136. doi: 10.1016/j.lungcan.2020.07.016. Epub 2020 Jul 16. Lung Cancer. 2020. PMID: 32702569

7

USP46 Inhibits Cell Proliferation in Lung Cancer through PHLPP1/AKT Pathway.

Wang W, Chen M, Xu H, Lv D, Zhou S, Yang H. Wang W, et al. Among authors: lv d. Biomed Res Int. 2020 Sep 23;2020:2509529. doi: 10.1155/2020/2509529. eCollection 2020. Biomed Res Int. 2020. PMID: 33029497 Free PMC article.

8

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.

Shi Y, Hu X, Zhang S, Lv D, Wu L, Yu Q, Zhang Y, Liu L, Wang X, Cheng Y, Ma Z, Niu H, Wang D, Feng J, Huang C, Liu C, Zhao H, Li J, Zhang X, Jiang Y, Gu C. Shi Y, et al. Among authors: lv d. Lancet Respir Med. 2021 Aug;9(8):829-839. doi: 10.1016/S2213-2600(20)30455-0. Epub 2021 Mar 26. Lancet Respir Med. 2021. PMID: 33780662 Clinical Trial.

9

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.

Song Z, Lv D, Chen S, Huang J, Wang L, Xu S, Chen H, Wang G, Lin Q. Song Z, et al. Among authors: lv d. Front Oncol. 2021 May 7;11:657283. doi: 10.3389/fonc.2021.657283. eCollection 2021. Front Oncol. 2021. PMID: 34026634 Free PMC article.

10

Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling.

Wang W, Xia X, Chen K, Chen M, Meng Y, Lv D, Yang H. Wang W, et al. Among authors: lv d. Front Oncol. 2021 Jun 8;11:665045. doi: 10.3389/fonc.2021.665045. eCollection 2021. Front Oncol. 2021. PMID: 34168988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,649 results

Search Page

Filters